CAVO, MICHELE
CAVO, MICHELE
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Radiologic findings of Fusarium pneumonia in neutropenic patients
In corso di stampa Sassi, Claudia; Stanzani, Marta; Lewis, Russell E.; Vianelli, Nicola; Tarsi, Andrea; Poerio, Antonio; Cavo, Michele; Battista, Giuseppe
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma
2025 Talarico, Marco; Vischini, Gisella; Barbato, Simona; Restuccia, Roberta; Masci, Simone; Sacchetti, Ilaria; Manzato, Enrica; Ghibellini, Stefano; Puppi, Michele; Iezza, Miriam; Rizzello, Ilaria; Pantani, Lucia; Tacchetti, Paola; Borsi, Enrica; Solli, Vincenza; Terragna, Carolina; Agostinelli, Claudio; La Manna, Gaetano; Cavo, Michele; Zamagni, Elena; Mancuso, Katia
Correction: Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma
2025 Mancuso, K.; Barbato, S.; Raimondo, F. D.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zamagni, E.; Zambello, R.; Cavo, M.
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma
2025 Talarico, M.; Barbato, S.; Cattabriga, A.; Sacchetti, I.; Manzato, E.; Restuccia, R.; Masci, S.; Bigi, F.; Puppi, M.; Iezza, M.; Rizzello, I.; Mancuso, K.; Pantani, L.; Tacchetti, P.; Nanni, C.; Cavo, M.; Zamagni, E.
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
2025 Musto, P.; Engelhardt, M.; van de Donk, N. W. C. J.; Gay, F.; Terpos, E.; Einsele, H.; Fernández de Larrea, C.; Sgherza, N.; Bolli, N.; Katodritou, E.; Gentile, M.; Royer, B.; Derudas, D.; Jelinek, T.; Zamagni, E.; Rosiñol, L.; Paiva, B.; Caers, J.; Kaiser, M.; Beksac, M.; Hájek, R.; Spencer, A.; Ludwig, H.; Cavo, M.; Bladé, J.; Moreau, P.; Mateos, M. V.; San-Miguel, J. F.; Dimopoulos, M. A.; Boccadoro, M.; Sonneveld, P.
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
2025 Talarico, M.; Barbato, S.; Maisnar, V.; Delimpasi, S.; Puppi, M.; Rizzello, I.; Pantani, L.; Tacchetti, P.; Martello, M.; Vigliotta, I.; Terragna, C.; Cavo, M.; Zamagni, E.; Mancuso, K.
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma
2025 Mancuso, K.; Barbato, S.; Di Raimondo, F.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zamagni, E.; Zambello, R.; Cavo, M.
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
2025 Salvestrini, Valentina; Conti, Gabriele; D'Amico, Federica; Cristiano, Gianluca; Candela, Marco; Cavo, Michele; Turroni, Silvia; Curti, Antonio
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma
2025 Mancuso, Katia; Barbato, Simona; Talarico, Marco; Tacchetti, Paola; Zamagni, Elena; Cavo, Michele
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS
2025 Mancuso, K.; Talarico, M.; Manzato, E.; Barbato, S.; Tacchetti, P.; Zamagni, E.; Cavo, M.
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home
2025 Bigi, F.; Fiacchini, M.; Restuccia, R.; Masci, S.; Mazzocchetti, G.; Talarico, M.; Puppi, M.; Sacchetti, I.; Manzato, E.; Iezza, M.; Mancuso, K.; Sartor, C.; Pantani, L.; Tacchetti, P.; Alatif, R. A.; Pastore, E.; Barbato, S.; Cavo, M.; Zamagni, E.; Rizzello, I.
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma
2025 Poletti, A; Taurisano, B; Mazzocchetti, G; Lionetti, M; Martello, M; Vuong, Vm; Solli, V; Marzocchi, G; Maeda, A; Vigliotta, I; Borsi, E; Armuzzi, S; Pistis, I; Marella, A; Fabris, S; Tacchetti, P; Mancuso, K; Rizzello, I; Pantani, L; Testoni, N; Cavo, M; Zamagni, E; Bolli, N; Terragna, C.
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma
2024 Tacchetti, P.; Talarico, M.; Barbato, S.; Pantani, L.; Mancuso, K.; Rizzello, I.; Zamagni, E.; Cavo, M.
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
2024 Hungria, V.; Robak, P.; Hus, M.; Zherebtsova, V.; Ward, C.; Ho, P. J.; Ribas de Almeida, A. C.; Hajek, R.; Kim, K.; Grosicki, S.; Sia, H.; Bryant, A.; Pitombeira de Lacerda, M.; Martinez, G. A.; Balari, A. M. S.; Sandhu, I.; Cerchione, C.; Ganly, P.; Dimopoulos, M.; Fu, C.; Garg, M.; Abdallah, A. -O.; Oriol, A.; Gatt, M. E.; Cavo, M.; Rifkin, R.; Fujisaki, T.; Mielnik, M.; Pirooz, N.; Mckeown, A.; Mcnamara, S.; Zhou, X.; Nichols, M.; Lewis, E.; Rogers, R.; Baig, H.; Eccersley, L.; Roy-Ghanta, S.; Opalinska, J.; Mateos, M. -V.
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
2024 Dimopoulos, M. A.; Beksac, M.; Pour, L.; Delimpasi, S.; Vorobyev, V.; Quach, H.; Spicka, I.; Radocha, J.; Robak, P.; Kim, K.; Cavo, M.; Suzuki, K.; Morris, K.; Pompilus, F.; Phillips-Jones, A.; Zhou, X. L.; Fulci, G.; Sule, N.; Kremer, B. E.; Opalinska, J.; Mateos, M. -V.; Trudel, S.
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma
2024 Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A.
Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma
2024 Tacchetti, Paola; Barbato, Simona; Mancuso, Katia; Zamagni, Elena; Cavo, Michele
Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells
2024 Pensato V.; Laginestra M.A.; Falvo P.; Orecchioni S.; Talarico G.; De Marchi E.; Bruno S.; Mongiorgi S.; Mitola G.; Bertolini F.; Adinolfi E.; Cavo M.; Curti A.; Salvestrini V.
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients
2024 Vigliotta, Ilaria; Solli, Vincenza; Armuzzi, Silvia; Martello, Marina; Poletti, Andrea; Taurisano, Barbara; Pistis, Ignazia; Mazzocchetti, Gaia; Borsi, Enrica; Pantani, Lucia; Marzocchi, Giulia; Testoni, Nicoletta; Zamagni, Elena; Terracciano, Mario; Tononi, Paola; Garonzi, Marianna; Ferrarini, Alberto; Manaresi, Nicolò; Cavo, Michele; Terragna, Carolina
Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study
2024 Mancuso, K.; Mina, R.; Rocchi, S.; Antonioli, E.; Petrucci, M. T.; Fazio, F.; Gozzetti, A.; Salvini, M.; Cartia, C. S.; Bertuglia, G.; Patriarca, F.; Dalla Palma, A. B.; Barbato, S.; De Cicco, G.; Bigi, F.; Favero, E.; Tacchetti, P.; Pantani, L.; Rizzello, I.; Puppi, M.; Talarico, M.; Solli, V.; Kanapari, A.; Cavo, M.; Zamagni, E.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Radiologic findings of Fusarium pneumonia in neutropenic patients | Sassi, Claudia; Stanzani, Marta; Lewis, Russell E.; Vianelli, Nicola; Tarsi, Andrea; Poerio, Anto...nio; Cavo, Michele; Battista, Giuseppe | 9999-01-01 | MYCOSES | - | 1.01 Articolo in rivista | - |
| Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma | Talarico, Marco; Vischini, Gisella; Barbato, Simona; Restuccia, Roberta; Masci, Simone; Sacchetti..., Ilaria; Manzato, Enrica; Ghibellini, Stefano; Puppi, Michele; Iezza, Miriam; Rizzello, Ilaria; Pantani, Lucia; Tacchetti, Paola; Borsi, Enrica; Solli, Vincenza; Terragna, Carolina; Agostinelli, Claudio; La Manna, Gaetano; Cavo, Michele; Zamagni, Elena; Mancuso, Katia | 2025-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-15-1672690.pdf |
| Correction: Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma | Mancuso, K.; Barbato, S.; Raimondo, F. D.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zam...agni, E.; Zambello, R.; Cavo, M. | 2025-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-17-02555.pdf |
| Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma | Talarico, M.; Barbato, S.; Cattabriga, A.; Sacchetti, I.; Manzato, E.; Restuccia, R.; Masci, S.; ...Bigi, F.; Puppi, M.; Iezza, M.; Rizzello, I.; Mancuso, K.; Pantani, L.; Tacchetti, P.; Nanni, C.; Cavo, M.; Zamagni, E. | 2025-01-01 | JOURNAL OF BONE ONCOLOGY | - | 1.01 Articolo in rivista | 1-s2.0-S2212137425000107-main.pdf |
| European Myeloma Network Group review and consensus statement on primary plasma cell leukemia | Musto, P.; Engelhardt, M.; van de Donk, N. W. C. J.; Gay, F.; Terpos, E.; Einsele, H.; Fernández ...de Larrea, C.; Sgherza, N.; Bolli, N.; Katodritou, E.; Gentile, M.; Royer, B.; Derudas, D.; Jelinek, T.; Zamagni, E.; Rosiñol, L.; Paiva, B.; Caers, J.; Kaiser, M.; Beksac, M.; Hájek, R.; Spencer, A.; Ludwig, H.; Cavo, M.; Bladé, J.; Moreau, P.; Mateos, M. V.; San-Miguel, J. F.; Dimopoulos, M. A.; Boccadoro, M.; Sonneveld, P. | 2025-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | musto_2025.pdf |
| Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies? | Talarico, M.; Barbato, S.; Maisnar, V.; Delimpasi, S.; Puppi, M.; Rizzello, I.; Pantani, L.; Tacc...hetti, P.; Martello, M.; Vigliotta, I.; Terragna, C.; Cavo, M.; Zamagni, E.; Mancuso, K. | 2025-01-01 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | s00432-025-06326-3.pdf |
| Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma | Mancuso, K.; Barbato, S.; Di Raimondo, F.; Gay, F.; Musto, P.; Offidani, M.; Petrucci, M. T.; Zam...agni, E.; Zambello, R.; Cavo, M. | 2025-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-17-01168-v2.pdf |
| Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients | Salvestrini, Valentina; Conti, Gabriele; D'Amico, Federica; Cristiano, Gianluca; Candela, Marco; ...Cavo, Michele; Turroni, Silvia; Curti, Antonio | 2025-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cancer Medicine - 2025 - Salvestrini - Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction.pdf |
| Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma | Mancuso, Katia; Barbato, Simona; Talarico, Marco; Tacchetti, Paola; Zamagni, Elena; Cavo, Michele | 2025-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | Idecabtagene vicleucel ide-cel for the treatment of triple-class exposed relapsed and refractory multiple myeloma.pdf |
| T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS | Mancuso, K.; Talarico, M.; Manzato, E.; Barbato, S.; Tacchetti, P.; Zamagni, E.; Cavo, M. | 2025-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-17-01514.pdf |
| Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home | Bigi, F.; Fiacchini, M.; Restuccia, R.; Masci, S.; Mazzocchetti, G.; Talarico, M.; Puppi, M.; Sac...chetti, I.; Manzato, E.; Iezza, M.; Mancuso, K.; Sartor, C.; Pantani, L.; Tacchetti, P.; Alatif, R. A.; Pastore, E.; Barbato, S.; Cavo, M.; Zamagni, E.; Rizzello, I. | 2025-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | s10238-025-01683-2.pdf; 10238_2025_1683_MOESM1_ESM.docx |
| Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma | Poletti, A; Taurisano, B; Mazzocchetti, G; Lionetti, M; Martello, M; Vuong, Vm; Solli, V; Marzocc...hi, G; Maeda, A; Vigliotta, I; Borsi, E; Armuzzi, S; Pistis, I; Marella, A; Fabris, S; Tacchetti, P; Mancuso, K; Rizzello, I; Pantani, L; Testoni, N; Cavo, M; Zamagni, E; Bolli, N; Terragna, C. | 2025-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 12063-Article+Text-87603-1-10-20250515.pdf |
| Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma | Tacchetti, P.; Talarico, M.; Barbato, S.; Pantani, L.; Mancuso, K.; Rizzello, I.; Zamagni, E.; Ca...vo, M. | 2024-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.01 Articolo in rivista | - |
| Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma | Hungria, V.; Robak, P.; Hus, M.; Zherebtsova, V.; Ward, C.; Ho, P. J.; Ribas de Almeida, A. C.; H...ajek, R.; Kim, K.; Grosicki, S.; Sia, H.; Bryant, A.; Pitombeira de Lacerda, M.; Martinez, G. A.; Balari, A. M. S.; Sandhu, I.; Cerchione, C.; Ganly, P.; Dimopoulos, M.; Fu, C.; Garg, M.; Abdallah, A. -O.; Oriol, A.; Gatt, M. E.; Cavo, M.; Rifkin, R.; Fujisaki, T.; Mielnik, M.; Pirooz, N.; Mckeown, A.; Mcnamara, S.; Zhou, X.; Nichols, M.; Lewis, E.; Rogers, R.; Baig, H.; Eccersley, L.; Roy-Ghanta, S.; Opalinska, J.; Mateos, M. -V. | 2024-01-01 | THE NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
| Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma | Dimopoulos, M. A.; Beksac, M.; Pour, L.; Delimpasi, S.; Vorobyev, V.; Quach, H.; Spicka, I.; Rado...cha, J.; Robak, P.; Kim, K.; Cavo, M.; Suzuki, K.; Morris, K.; Pompilus, F.; Phillips-Jones, A.; Zhou, X. L.; Fulci, G.; Sule, N.; Kremer, B. E.; Opalinska, J.; Mateos, M. -V.; Trudel, S. | 2024-01-01 | THE NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
| Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma | Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathi...os; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A. | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 11470-Article Text-83474-2-10-20240626.pdf |
| Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma | Tacchetti, Paola; Barbato, Simona; Mancuso, Katia; Zamagni, Elena; Cavo, Michele | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-02337.pdf |
| Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells | Pensato V.; Laginestra M.A.; Falvo P.; Orecchioni S.; Talarico G.; De Marchi E.; Bruno S.; Mongio...rgi S.; Mitola G.; Bertolini F.; Adinolfi E.; Cavo M.; Curti A.; Salvestrini V. | 2024-01-01 | STEM CELLS | - | 1.01 Articolo in rivista | Pensato-2024_compressed.pdf |
| Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients | Vigliotta, Ilaria; Solli, Vincenza; Armuzzi, Silvia; Martello, Marina; Poletti, Andrea; Taurisano..., Barbara; Pistis, Ignazia; Mazzocchetti, Gaia; Borsi, Enrica; Pantani, Lucia; Marzocchi, Giulia; Testoni, Nicoletta; Zamagni, Elena; Terracciano, Mario; Tononi, Paola; Garonzi, Marianna; Ferrarini, Alberto; Manaresi, Nicolò; Cavo, Michele; Terragna, Carolina | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-02929.pdf; cancers-16-02929-s001.zip |
| Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study | Mancuso, K.; Mina, R.; Rocchi, S.; Antonioli, E.; Petrucci, M. T.; Fazio, F.; Gozzetti, A.; Salvi...ni, M.; Cartia, C. S.; Bertuglia, G.; Patriarca, F.; Dalla Palma, A. B.; Barbato, S.; De Cicco, G.; Bigi, F.; Favero, E.; Tacchetti, P.; Pantani, L.; Rizzello, I.; Puppi, M.; Talarico, M.; Solli, V.; Kanapari, A.; Cavo, M.; Zamagni, E. | 2024-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cancer Medicine - 2024 - Mancuso - Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal.pdf; cam470266-sup-0001-datas1.docx |